These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21077202)

  • 1. Genotype-phenotype correlation in DTDST dysplasias: Atelosteogenesis type II and diastrophic dysplasia variant in one family.
    Dwyer E; Hyland J; Modaff P; Pauli RM
    Am J Med Genet A; 2010 Dec; 152A(12):3043-50. PubMed ID: 21077202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A compound heterozygote of novel and recurrent DTDST mutations results in a novel intermediate phenotype of Desbuquois dysplasia, diastrophic dysplasia, and recessive form of multiple epiphyseal dysplasia.
    Miyake A; Nishimura G; Futami T; Ohashi H; Chiba K; Toyama Y; Furuichi T; Ikegawa S
    J Hum Genet; 2008; 53(8):764-768. PubMed ID: 18553123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.
    Rossi A; van der Harten HJ; Beemer FA; Kleijer WJ; Gitzelmann R; Steinmann B; Superti-Furga A
    Hum Genet; 1996 Dec; 98(6):657-61. PubMed ID: 8931695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype.
    Karniski LP
    Hum Mol Genet; 2001 Jul; 10(14):1485-90. PubMed ID: 11448940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A compound heterozygote harboring novel and recurrent DTDST mutations with intermediate phenotype between atelosteogenesis type II and diastrophic dysplasia.
    Maeda K; Miyamoto Y; Sawai H; Karniski LP; Nakashima E; Nishimura G; Ikegawa S
    Am J Med Genet A; 2006 Jun; 140(11):1143-7. PubMed ID: 16642506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance.
    Rossi A; Superti-Furga A
    Hum Mutat; 2001 Mar; 17(3):159-71. PubMed ID: 11241838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia.
    Bonafé L; Hästbacka J; de la Chapelle A; Campos-Xavier AB; Chiesa C; Forlino A; Superti-Furga A; Rossi A
    J Med Genet; 2008 Dec; 45(12):827-31. PubMed ID: 18708426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A compound heterozygote SLC26A2 mutation resulting in robin sequence, mild limbs shortness, accelerated carpal ossification, and multiple epiphysial dysplasia in two Brazilian sisters. A new intermediate phenotype between diastrophic dysplasia and recessive multiple epiphyseal dysplasia.
    Zechi-Ceide RM; Moura PP; Raskin S; Richieri-Costa A; Guion-Almeida ML
    Am J Med Genet A; 2013 Aug; 161A(8):2088-94. PubMed ID: 23840040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal recessive multiple epiphyseal dysplasia with homozygosity for C653S in the DTDST gene: double-layer patella as a reliable sign.
    Mäkitie O; Savarirayan R; Bonafé L; Robertson S; Susic M; Superti-Furga A; Cole WG
    Am J Med Genet A; 2003 Oct; 122A(3):187-92. PubMed ID: 12966518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.
    Hästbacka J; Superti-Furga A; Wilcox WR; Rimoin DL; Cohn DH; Lander ES
    Am J Hum Genet; 1996 Feb; 58(2):255-62. PubMed ID: 8571951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular characterization of Diastrophic Dysplasia in the Portuguese population.
    Barbosa M; Sousa AB; Medeira A; Lourenço T; Saraiva J; Pinto-Basto J; Soares G; Fortuna AM; Superti-Furga A; Mittaz L; Reis-Lima M; Bonafé L
    Clin Genet; 2011 Dec; 80(6):550-7. PubMed ID: 21155763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations.
    Superti-Furga A; Rossi A; Steinmann B; Gitzelmann R
    Am J Med Genet; 1996 May; 63(1):144-7. PubMed ID: 8723100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression and cellular distribution of diastrophic dysplasia sulfate transporter (DTDST) gene mutations in HEK cells.
    Karniski LP
    Hum Mol Genet; 2004 Oct; 13(19):2165-71. PubMed ID: 15294877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal recessive multiple epiphyseal dysplasia in a Korean girl caused by novel compound heterozygous mutations in the DTDST (SLC26A2) gene.
    Cho TJ; Kim OH; Lee HR; Shin SJ; Yoo WJ; Park WY; Park SS; Cho SI; Choi IH
    J Korean Med Sci; 2010 Jul; 25(7):1105-8. PubMed ID: 20592910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation.
    Superti-Furga A; Neumann L; Riebel T; Eich G; Steinmann B; Spranger J; Kunze J
    J Med Genet; 1999 Aug; 36(8):621-4. PubMed ID: 10465113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity.
    Czarny-Ratajczak M; Lohiniva J; Rogala P; Kozlowski K; Perälä M; Carter L; Spector TD; Kolodziej L; Seppänen U; Glazar R; Królewski J; Latos-Bielenska A; Ala-Kokko L
    Am J Hum Genet; 2001 Nov; 69(5):969-80. PubMed ID: 11565064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastrophic dysplasia and atelosteogenesis type II as expression of compound heterozygosis: first report of a Mexican patient and genotype-phenotype correlation.
    Macías-Gómez NM; Mégarbané A; Leal-Ugarte E; Rodríguez-Rojas LX; Barros-Núñez P
    Am J Med Genet A; 2004 Aug; 129A(2):190-2. PubMed ID: 15316973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production.
    Rossi A; Kaitila I; Wilcox WR; Rimoin DL; Steinmann B; Cetta G; Superti-Furga A
    Matrix Biol; 1998 Oct; 17(5):361-9. PubMed ID: 9822202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype.
    Forlino A; Piazza R; Tiveron C; Della Torre S; Tatangelo L; Bonafè L; Gualeni B; Romano A; Pecora F; Superti-Furga A; Cetta G; Rossi A
    Hum Mol Genet; 2005 Mar; 14(6):859-71. PubMed ID: 15703192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygosity for a novel DTDST mutation in a child with a 'broad bone-platyspondylic' variant of diastrophic dysplasia.
    Mégarbané A; Haddad FA; Haddad-Zebouni S; Achram M; Eich G; Le Merrer M; Superti-Furga A
    Clin Genet; 1999 Jul; 56(1):71-6. PubMed ID: 10466420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.